Drug Development

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Articles

Gottlieb promoted the development of biosimilars and safer opioid packaging at a briefing sponsored by Alliance for a Stronger FDA and the Pew Charitable Trusts.

Gottlieb Encourages Biosimilars and Safer Opioid Packaging

The Awards honor innovations in drug delivery and packaging, for better patient safety and compliance.

Pharmapack Award Winners of 2018 Revealed

Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.

J&J and Theravance in $1-Billion Deal for Inflammatory Bowel Disease

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.

Impurity Testing

Manufacturers tackle regulatory and competitive issues to develop complex therapies and biosimilars.


Opportunities and Obstacles for Generic Drugs

Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform.

Accelerating Early Drug Development with Translational Pharmaceutics

Jan Vertommen is senior director, Product Development & Manufacturing, at Lonza.

Industry lessons from a fast-track technology transfer of a soft-gelatin capsule (softgel) are multifold. This case study reviews the success factors for effective execution of the technology transfer, which include: strong relationship between the customer, the contract development and manufacturing organization, and other partners based on deep knowledge in the technology; established and proven quality-by-design processes; risk mitigation management; project leadership; flawless execution; and mutual trust.

Case Study: Fast-Track Technology Transfer of a Soft-Gelatin Capsule

Cambrex invests in development and laboratory facilities and adds staff.

Cambrex Expands API Development at Iowa Facility

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics. 

Bigger is Better in Samsung's Approach to Biomanufacturing

The new Acquity Arc Bio System by Waters is specifically engineered to enable efficient transfer and improvement of bioseparation analytical methods.

Formulation and Drug Delivery